177 related articles for article (PubMed ID: 38582286)
41. Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.
Chalandon Y; Mamez AC; Giannotti F; Beauverd Y; Dantin C; Mahne E; Mappoura M; Bernard F; de Ramon Ortiz C; Stephan C; Morin S; Ansari M; Simonetta F; Masouridi-Levrat S
Transplant Cell Ther; 2022 Nov; 28(11):765.e1-765.e9. PubMed ID: 35953029
[TBL] [Abstract][Full Text] [Related]
42. Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research.
Strouse C; Richardson P; Prentice G; Korman S; Hume R; Nejadnik B; Horowitz MM; Saber W
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1306-1312. PubMed ID: 27108694
[TBL] [Abstract][Full Text] [Related]
43. Identification and Management: Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Eelated to Hematopoietic Stem Cell Transplantation
.
Ní Chonghaile M; Wolownik K
Clin J Oncol Nurs; 2018 Feb; 22(1):E7-E17. PubMed ID: 29350698
[TBL] [Abstract][Full Text] [Related]
44. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
45. Two Cases of Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Thioguanine Treatment for Acute Lymphoblastic Leukemia.
Gruhn B; Brodt G; Mentzel HJ; Ernst J
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e572-e575. PubMed ID: 33885036
[TBL] [Abstract][Full Text] [Related]
46. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.
Bonifazi F; Barbato F; Ravaioli F; Sessa M; Defrancesco I; Arpinati M; Cavo M; Colecchia A
Front Immunol; 2020; 11():489. PubMed ID: 32318059
[TBL] [Abstract][Full Text] [Related]
47. Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.
Stutz L; Halter JP; Heim D; Passweg JR; Medinger M
Bone Marrow Transplant; 2022 Mar; 57(3):391-398. PubMed ID: 34980902
[TBL] [Abstract][Full Text] [Related]
48. Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
Nishida M; Kahata K; Hayase E; Shigematsu A; Sato M; Kudo Y; Omotehara S; Iwai T; Sugita J; Shibuya H; Shimizu C; Teshima T
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1896-1900. PubMed ID: 29803752
[TBL] [Abstract][Full Text] [Related]
49. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
Al Jefri AH; Abujazar H; Al-Ahmari A; Al Rawas A; Al Zahrani Z; Alhejazi A; Bekadja MA; Ibrahim A; Lahoucine M; Ousia S; Bazarbachi A
Bone Marrow Transplant; 2017 Apr; 52(4):588-591. PubMed ID: 27892944
[TBL] [Abstract][Full Text] [Related]
50. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and Safety of Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Yang L; Qi J; Pan T; You T; Ruan C; Han Y
Semin Thromb Hemost; 2019 Nov; 45(8):767-777. PubMed ID: 31627217
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant.
Pai RK; van Besien K; Hart J; Artz AS; O'Donnell PH
Leuk Lymphoma; 2012 Aug; 53(8):1552-7. PubMed ID: 22280517
[TBL] [Abstract][Full Text] [Related]
53. Higher Cryopreserved CD34
Kato S; Konuma T; Monna-Oiwa M; Isobe M; Takahashi S; Nannya Y
Transplant Cell Ther; 2022 Nov; 28(11):779.e1-779.e9. PubMed ID: 35995391
[TBL] [Abstract][Full Text] [Related]
54. Utility of liver stiffness measurement in the diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.
Inoue Y; Saitoh S; Denpo H; Yamaguchi K; Kubota K; Taya Y; Wake A; Masuda A; Ishiwata K
J Med Ultrason (2001); 2024 Apr; 51(2):311-321. PubMed ID: 38112930
[TBL] [Abstract][Full Text] [Related]
55. Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
Ho VT; Martin AS; Pérez WS; Steinert P; Zhang MJ; Chirnomas D; Hoang CJ; Loberiza FR; Saber W
Biol Blood Marrow Transplant; 2020 May; 26(5):884-892. PubMed ID: 31891815
[TBL] [Abstract][Full Text] [Related]
56. Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience.
Mehra V; Tetlow S; Choy A; de Lavallade H; Kulasekararaj A; Krishnamurthy P; Avenoso D; Marsh J; Potter V; Mufti G; Pagliuca A; Gandhi S
Am J Transplant; 2021 Feb; 21(2):864-869. PubMed ID: 33037770
[TBL] [Abstract][Full Text] [Related]
57. Defibrotide: An Oligonucleotide for Sinusoidal Obstruction Syndrome.
Aziz MT; Kakadiya PP; Kush SM; Weigel K; Lowe DK
Ann Pharmacother; 2018 Feb; 52(2):166-174. PubMed ID: 28914546
[TBL] [Abstract][Full Text] [Related]
58. Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study.
Ruutu T; Peczynski C; Houhou M; Polge E; Mohty M; Kröger N; Moiseev I; Penack O; Salooja N; Schoemans H; Duarte RF; Schroeder T; Passweg J; Wulf GG; Ganser A; Sica S; Arat M; Salmenniemi U; Broers AEC; Bourhis JH; Rambaldi A; Maertens J; Halaburda K; Zuckerman T; Labussière-Wallet H; Basak G; Koenecke C; Perić Z
Bone Marrow Transplant; 2023 Nov; 58(11):1209-1214. PubMed ID: 37573397
[TBL] [Abstract][Full Text] [Related]
59. Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
Dalle JH; Giralt SA
Biol Blood Marrow Transplant; 2016 Mar; 22(3):400-9. PubMed ID: 26431626
[TBL] [Abstract][Full Text] [Related]
60. Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients.
Maximova N; Granzotto M; Barbieri F; Marcuzzi A; Tommasini A; Monasta L; Simeone R; Zanon D; Sala R
Cancer Med; 2019 Mar; 8(3):890-901. PubMed ID: 30690926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]